Federico Ghignone
@FedeGhigno
Followers
516
Following
631
Media
48
Statuses
2K
Surgeon @ Santa Maria delle Croci (Ravenna - IT). Colorectal | IBD | Clinical Audit | #GerOnc Assistant Editor @ejsotweets Virtus & Bologna FC supporter
Bologna, Emilia Romagna
Joined April 2013
Is Standardized Right Hemicolectomy with D2 Lymphadenectomy Enough to Limit Local Recurrence in Adenocarcinoma of the Right Colon?" 📌 400 stage I-III colon cancer pts ⚠️ LR = 2.5% 🚨 Main risk factor for LR ➡️ cancer in the proximal transverse colon
journals.lww.com
versus distant recurrence. Summary Background Data: While CME with central vascular ligation is advocated to improve oncologic outcomes in colon cancer, its true impact remains controversial. Most...
1
1
1
Ten steps towards better perioperative intravenous fluid therapy ➡️ https://t.co/TyxodKCPI4 💧 IV fluids are drugs — both deficit and overload worsen outcomes, yet perioperative prescribing is often overlooked and delegated to juniors 🩺 The paper stresses ABCDE assessment and
0
58
151
Percutaneous cholecystostomy should serve as a bridge to interval cholecystectomy in patients with contraindications to immediate surgery, specifically those with sepsis and acute cholecystitis, with IC ideally performed 8-13 weeks post-PC. https://t.co/rGMAtIMVZd
6
77
265
A 3-year structured exercise program after adjuvant chemotherapy for colon cancer improved disease-free and overall survival, physical functioning, and fitness, as compared with health education alone. Full CHALLENGE phase 3 trial results and Research Summary:
2
24
89
Took a while and a lot of effort, but Finally the long-term outcomes of #Crohnsurg study will come out in #DLD. Surprisingly, no significant difference in follow up comparing complicated and uncomplicated the CD patients, with some potencial medical overtreatment after surgery
1
7
24
A study led by @MayoClinic surgeons shows total neoadjuvant therapy followed by surgery to treat advanced #RectalCancer leads to excellent outcomes, including low recurrence and a high percentage of cancer-specific survival. Read the study to learn more: https://t.co/EN2CKxgSNs
0
9
19
Amigos gastroenterólogos/cirujanos/medicos de @latamccr @LatamUrg , nos dan una mano contestando esta encuesta de 1 minuto liderada por @NRotholtz @OncologiaHA . Fundamental para entender el manejo de Diverticulitis en la región. Retweet también se agradece mucho! @sopacipy
0
10
10
Repeated surgery for recurrence is not a risk factor for conversion in patients undergoing laparoscopic ileo-colonic resection for Crohn disease https://t.co/oSQskaCg8n another important @SurgJournal publication from @FedeGhigno and @CleveClinicFL alumnus @3isac 🇮🇹
0
7
15
Redo lap surgery for recurrent ileo-colonic CD takes longer operative time, but it’s worth! Recurrent disease is not a risk factor for conversion with similar outcomes to primary resection https://t.co/V0HMkCuEWL
@Unibo @AUSLRomagna @SWexner @nlavellaneda @IBDMD @YouSICCR
2
4
9
Thank you @FedeGhigno for highlighting this important @SurgJournal publication
Redo lap surgery for recurrent ileo-colonic CD takes longer operative time, but it’s worth! Recurrent disease is not a risk factor for conversion with similar outcomes to primary resection https://t.co/V0HMkCuEWL
@Unibo @AUSLRomagna @SWexner @nlavellaneda @IBDMD @YouSICCR
0
6
15
Redo lap surgery for recurrent ileo-colonic CD takes longer operative time, but it’s worth! Recurrent disease is not a risk factor for conversion with similar outcomes to primary resection https://t.co/V0HMkCuEWL
@Unibo @AUSLRomagna @SWexner @nlavellaneda @IBDMD @YouSICCR
2
4
9
The most practice changing trial from #ASCO25 is now live on @NEJM .If this was a drug, this would be approved today. Globally relevant and low-cost intervention that is not only delaying relapse but actually improving survival. Perfect case example of a #cancergroundshot trial.
19
301
960
Our current thoughts on #Neoadjuvant Therapy for #Rectal #Cancer. This a very complex + continually evolving area, so thank you @AnnSurgOncol for the opportunity to summarize current standards and issues. https://t.co/sB1fX8LWgl
1
23
47
https://t.co/90MOM99mJt I have taken care of 1000s of older pts with cancer. This video helps them and their family members to approach this decision in a more informative way @3isac
1
3
2
Will only increase in the future Neoadjuvant chemotherapy in locally advanced colon cancer: A systematic review with proportional meta-analysis - European Journal of Surgical Oncology
1
9
19
We have an amazing opportunity for someone to do a 3 year IBD focused data science PhD in Edinburgh as part of a fully funded OPEN-IBD fellowship. It’s a fantastic department, in a beautiful city, and the clinical commitment will be ~20% to recruit patients to OPEN IBD with the
0
31
76
Great pearls of wisdom about frailty from @CleveClinicFL alumnus @SaurNicole @pennsurgery #ICDS25 @SIOGorg @ESSOnews @escp_tweets
0
7
10
1823 STEMI patients with MVD randomized to angiography-derived FFR vs. conventional angiography guidance complete revasc
@SimoneBiscaglia did it again!!! After the @theFIRE_trial we completed the sample size of the #AIRtrial
1
5
18
@SimoneBiscaglia did it again!!! After the @theFIRE_trial we completed the sample size of the #AIRtrial
elementrials.org
AIR-STEMI Mission Accomplished
0
7
17